Company filings profile · CIK 0001855175
Contineum Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Contineum Therapeutics, Inc. (CTNM): 12 filings in the last 90 days vs 30 in the prior 90 (filing-velocity cooling ↓ · 0.4×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Nov 4, 2026. Source-linked, daily-refreshed.
Material 8-K events — Contineum Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Nov 3, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Sep 14, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 30, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 13, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | Item 5.07 | ↗ |
Watch Contineum Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Nov 4, 2026 | 144 | ↗ | |
| Nov 3, 2026 | 10-Q | 10-Q | ↗ |
| Nov 3, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Oct 28, 2026 | SCHEDULE 13G | ↗ | |
| Oct 28, 2026 | SCHEDULE 13G/A | ↗ | |
| Oct 22, 2026 | SCHEDULE 13G | ↗ | |
| Oct 1, 2026 | 144 | ↗ | |
| Sep 14, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Sep 8, 2026 | 4 | FORM 4 | ↗ |
| Sep 8, 2026 | 144 | ↗ | |
| Sep 1, 2026 | 144 | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 3, 2026 | 4 | FORM 4 | ↗ |
| Aug 3, 2026 | 144 | ↗ | |
| Aug 3, 2026 | 144 | ↗ | |
| Jul 30, 2026 | 10-Q | 10-Q | ↗ |
| Jul 30, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 27, 2026 | SCHEDULE 13G | ↗ | |
| Jul 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 13, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 10, 2026 | 4 | FORM 4 | ↗ |
| Jul 8, 2026 | 4 | FORM 4 | ↗ |
| Jul 8, 2026 | 144 | ↗ | |
| Jul 2, 2026 | 4 | FORM 4 | ↗ |
| Jul 1, 2026 | 4 | FORM 4 | ↗ |
| Jul 1, 2026 | 4 | FORM 4 | ↗ |
| Jul 1, 2026 | 144 | ↗ | |
| Jun 30, 2026 | 144 | ↗ | |
| Jun 30, 2026 | 144 | ↗ | |
| Jun 30, 2026 | 144 | ↗ | |
| Jun 26, 2026 | 4 | FORM 4 | ↗ |
| Jun 26, 2026 | 4 | FORM 4 | ↗ |
| Jun 26, 2026 | 4 | FORM 4 | ↗ |
| Jun 26, 2026 | 4 | FORM 4 | ↗ |
| Jun 26, 2026 | 4 | FORM 4 | ↗ |
| Jun 26, 2026 | 4 | FORM 4 | ↗ |
| Jun 26, 2026 | 4 | FORM 4 | ↗ |
| Jun 26, 2026 | 8-K | Item 5.07 | ↗ |
| Jun 1, 2026 | 4 | FORM 4 | ↗ |
| Jun 1, 2026 | 144 | ↗ |